Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35663414

Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion-Positive NSCLC.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
JTO Clin Res Rep
Publication date
2022 Jun
First author
Drilon A

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Drilon A
      type
      Author
    2. name
      Chiu CH
      type
      Author
    3. name
      Fan Y
      type
      Author
    4. name
      Cho BC
      type
      Author
    5. name
      Lu S
      type
      Author
    6. name
      Ahn MJ
      type
      Author
    7. name
      Krebs MG
      type
      Author
    8. name
      Liu SV
      type
      Author
    9. name
      John T
      type
      Author
    10. name
      Otterson GA
      type
      Author
    11. name
      Tan DSW
      type
      Author
    12. name
      Patil T
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Drilon A
      type
      Author
    2. name
      Chiu CH
      type
      Author
    3. name
      Fan Y
      type
      Author
    4. name
      Cho BC
      type
      Author
    5. name
      Lu S
      type
      Author
    6. name
      Ahn MJ
      type
      Author
    7. name
      Krebs MG
      type
      Author
    8. name
      Liu SV
      type
      Author
    9. name
      John T
      type
      Author
    10. name
      Otterson GA
      type
      Author
    11. name
      Tan DSW
      type
      Author
    12. name
      Patil T
      type
      Author
    bibliography ids
    1. nci-bib-a8fe9c8ca892bdd44008517a
    book metadata
    content sha256
    74204cc9ff4ce7524e2ff0983882f2ccd1ffd61e501d9b95ac995a6f8fb06c89
    document type
    citation
    dois
    1. 10.1016/j.jtocrr.2022.100332
    electronic publication date
    display
    2022 Apr 29
    precision
    day
    year
    2022
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:35663414
    immutable id
    pubmed:35663414@74204cc9ff4ce7524e2ff0983882f2ccd1ffd61e501d9b95ac995a6f8fb06c89
    journal
    abbreviation
    JTO Clin Res Rep
    issn electronic
    2666-3643
    issn print
    Source null
    issue
    6
    name
    JTO clinical and research reports
    nlm unique id
    101769967
    pages
    100332
    volume
    3
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      35663414
      provenance
      batch id
      9d150d55960e0c12aada
      provider
      NCBI PubMed ESummary
      record sha256
      112f1143d8e4d478fe63ebc9004f7bc666b09bb6583cf839318b0d445f32cfeb
      response sha256
      2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
      retrieved at
      2026-09-09T23:48:09.820498+00:00
      publication date
      display
      2022 Jun
      precision
      month
      year
      2022
      publication types
      1. Journal Article
      record status
      PubMed
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/35663414/
      title
      Long-Term Efficacy and Safety of Entrectinib in ROS1 Fusion-Positive NSCLC.

      Preserved source evidence · Not medical advice